Mylan Launches Generic Myfortic® Delayed-Release Tablets MarketWatch PITTSBURGH, Jan. 9, 2014 /PRNewswire via COMTEX/ -- Mylan Inc. (NASDAQ:MYL) today announced that its U.S.-based subsidiary Mylan Pharmaceuticals Inc. has launched Mycophenolic Acid Delayed-release Tablets, 180 mg and 360 mg. This product is ... Mylan Launches Generic Myfortic(R) Delayed-Release Tablets Mylan Launches Generic Myfortic |
